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A B S T R A C T
Pain typically accompanies acute herpes zoster and persists well beyond rash healing. Different types of pain are re-
ported by patients with herpes zoster. Current studies show that these types of pain vary with respect to their presence, lo-
cation, duration, intensity and quality, hence pain needs to be analyzed more thoroughly. The aim of the study was to as-
sess different components of pain in patients with herpes zoster. The study subjects were 46 patients diagnosed with
herpes zoster and selected out of 493 patients treated at the Pain Therapy Clinic, the outpatient facility of Zagreb Clinic
for Traumatology, in 2010. Measures used to assess pain and daily activities were the following: SF McGill Pain Ques-
tionnaire, Visual Analogue Scale, Self-Assessment of Life Satisfaction, Health Satisfaction and Enjoyment in Life. Anal-
gesic treatment together with demographic and clinical characteristics of patients were also taken into account. The re-
sults have shown that the patients report about spontaneous pain mostly in terms of the following qualities of high level
pain intensity: throbbing, aching, hot-burning and sharp. The results also demonstrate that herpes zoster pain signifi-
cantly affects the patients’ everyday living quality and their emotional health. Comprehensive assessment of pain is nec-
essary for clinical research about the epidemiology, natural history, pathophysiologic mechanisms, treatment, and pre-
vention of pain in herpes zoster.
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Introduction
Herpes zoster develops as a result of zoster virus reac-
tivation in the spinal cord roots of dorsal ganglia1. It is
characterized by typical rash in innervations areas of
cranial and spinal nerves. Statistical data for the U.S.A.
show the incidence of about 300 000 to 500 000 cases a
year, the incidence being higher in people above 60 years
of age2. Some authors report the incidence of herpes
zoster to be about 20% in the general population, where-
as it ranges up to 50% in the population group of 85 years
of age and above3. Herpes zoster begins and ends with
pain of varying intensity. Some authors report about dif-
ferent stages of pain. For example, Dworkin, White,
O’Connor and Hawkins4 differentiate between three
pain stages: acute pain (lasts 30 days after the onset of
rash); post-herpetic neuralgia (PHN – lasts about 120
days following the onset of rash), and subacute herpetic
neuralgia (SHN – lasts more than 30 days by can be
treated prior to making PHN diagnosis). In any case, the
most significant clinical manifestations of herpes zoster
include acute neuritis (acute pain or acute neuropathy)
and post-herpetic neuralgia (PHN, or chronic neuropa-
thy)1. Acute neuropathy is defined as pain occurring be-
fore and during the eruption of vesicles. Such a prodro-
mal pain can include different symptoms, e.g. itching,
burning, tickling, intense pain. It usually lasts about 30
days after vesicles have erupted. Most patients experi-
ence pain caused by acute neuritis in terms of rapid in-
crease in intensity and its slow diminishing2. Post-her-
petic neuralgia refers to pain that lasts more than 120
days following eruption of rash despite healing of skin le-
sions.
The incidence of chronic pain in general population is
relatively low, but it increases with age, so that in older
patients with herpes zoster it ranges from 9 to 14%.
Some authors state that about 50% of herpes zoster pa-
tients older than 60 years of age and almost 75% of those
older than 70 years of age will suffer from post-herpetic
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neuralgia. It ranges from 500 000 do 1 million cases in
the U.S.A. and about 200 000 in the United Kingdom3.
Although sex and race have been shown to have no im-
pact on the duration of pain, longer duration of painful
episodes has been noticed in female patients2. The ther-
apy of herpes zoster should commence as soon as possi-
ble, i.e. preferably immediately upon the occurrence of
rash. Basic therapeutic rationale is that by controlling
acute pain the risk of chronic pain is diminished and that
the intensity of therapeutic procedures should be propor-
tionate to the intensity of pain experienced by the pa-
tient. The use of antiviral therapy has proved to reduce
rash and shorten the duration of acute pain. Three drugs
are listed in reference literature as the most commonly
used ones, namely the acyclovir, famciclovir and valacy-
clovir; the two latter ones have proved the most efficient
and most appropriate in terms of consumption regimen5.
Some authors point out the efficacy of pregabalin in the
therapy of herpes zoster, as great doses of the drug allevi-
ate acute neuropathy6. In addition to these drugs, non-
-pharmacological procedures also play an important role
in the treatment of herpes zoster patients. Namely, ex-
tensive training of patients that would comprise clear ex-
planation of basic principles of the disease, treatment
plan, importance o antiviral therapy, the possibility of
spreading the infection to individuals who have not had
chickenpox5. Since herpes zoster is known for its painful
experience, it is important to assess self-reporting of pain
experience; hence the aim of our study was to find out
the types of pain occurring in herpes zoster infection.
Materials and Methods
The study subjects were 46 patients diagnosed with
herpes zoster and were selected out of 493 patients
treated at the Pain Therapy Clinic, the outpatient facility
of Clinic for Traumatology in Zagreb in 2010. There were
14 women (63.6%) and 8 men (36.4%), aged from 29 to 95
years (the average – 72 years).
The following measures were used in the assessment
of pain: SF McGill Pain Questionnaire and Visual Ana-
logue Scale. The Short Form McGill Pain Questionnaire
(SF-MPQ) was used to assess specific characteristics of
PHN7. It is based on two-factor model of pain, which dis-
tinguishes pain perception as sensory or affective. The
inventory consists of 15 items; 11 items assessing sen-
sory pain and 4 items assessing affective pain. Each item
consists of a word or phrase depicting the pain experi-
ence with answer ranging from »0«, denoting »absence of
particular pain«, to »3«, denoting »severe pain«. A sepa-
rate item measures the overall intensity of pain and
ranges from »0« to »5«. Internal consistency of the scale
varied from 0.705 to 0.82, depending on the sample8,16, al-
though most of the studies do not measure Cronbach á when us-
ing this specific inventory9.
Visual analogue scale (VAS) is a simple and frequently
used method for the assessment of variations in the in-
tensity of pain. A patient is asked to indicate his/her per-
ceived pain intensity along a 100 mm horizontal line, and
the rating is then measured from the left edge. The VAS
score correlates well with acute pain levels, although it
has an error of about 20 mm10.
Satisfaction with life and health, enjoying life and
self-reported inability to perform the activities of daily
living as a result of pain are shown as a subjective self-as-
sessment measure of pain in the Likert type scale from 1
to 5.
Analgesic treatment and demographic and clinical
characteristics of patients were also taken into consider-
ation.
Data were collected individually, in the institution, as
part of a greater study of pain syndromes. The study re-
ceived approval from ethical committee. All participants
have signed informed consent and no fee was paid them;
they could leave the research at their own will at any
time without any consequences.
The results were statistically analyzed by Statistica 7
software package. Statistical significance level was set at
95% (alpha = 95%), and the p value less than 0.05 was
considered as statistically significant.
Results and Discussion
Descriptive statistics for the measures of pain inten-
sity and quality are presented in Chart 1. The Short-
-Form McGill Pain Questionnaire assesses 15 specific
sensory and affective pain descriptors and provides a to-
tal score as well as sensory and affective subscale scores.
Figure 1 shows that the most commonly reported pain
sensations were the following: throbbing (M=1.93),
painful (M=1.8), burning (M=1.66) and sharp (M=1.66).
The most rarely reported pain sensations were the pun-
ishing (M=0.33) and splitting, or cracking pain (M=
0.33). The obtained results are in accordance with those
reported in reference literature, particularly in view of
the fact that the most common symptoms of herpes
zoster include the sensations of burning, pricking, itch-
ing and throbbing. Some studies have also shown that
more than 70% of patients most often report about the
following painful sensations: burning, painful, piercing,
throbbing, sharp and exhausting11,12. Bethany & Weaver




























































































Fig. 1. Distribution of average results for the types of pain (Mel-









(2007) in their review paper report about burning, pierc-
ing and painful as the most frequently described types of
pain in herpes zoster accompanied by severe itching at
sites of vesicular eruptions15.
The studies carries out so far show that the pain in
herpes zoster patients is most of the time described as be-
ing of mild intensity, although significant variations have
been reported in this respect12,13. Our study results have
shown that the intensity of pain ranges from mild to se-
vere in the majority of cases. It has also been noted that
the symptoms subside more rapidly in paints who do not
feel any or just mild pain, i.e. that the intensity of pain
indicates higher risk of prolonged painful sensations1.
All study subjects received pharmacological treat-
ment, and the choice of specific agent depended on the
intensity of pain. The patients reporting up to 4 on VAS,
i.e. mild to moderate pain, received non-opioid drugs, the
NSAR and ASK. When pain assessment ranged from 4 to
6 on VAS, i.e. moderate pain, the patients received tra-
madol, while for severe pain opiate drugs were adminis-
tered (VAS range from 6 to 10). As analgesic drugs need
to be gradually leveled to reach proper therapeutic dose,
the average therapeutic doze was about 1800 mg. After
six months of drug therapy the VAS results showed sig-
nificant diminishing of pain intensity.
The analysis of descriptive data about the duration of
pain has shown that the most common reason for the de-
velopment of chronic pain in patients with post-herpetic
neuralgia lies in inadequate treatment of pain occurring
in herpes zoster. In our study in as many as 80% of pa-
tients chronic pain developed as a result of their not
seeking medical attention before 3 to six months follow-
ing initial symptoms and subsiding of skin fluorescences.
As for other pain control procedures, it may be seen
that besides pharmacotherapy, physical therapy and acu-
puncture have been used most often and have yielded
satisfactory results. All study participants were adminis-
tered pharmacotherapy, while 68% of them used physical
therapy and 34% of patients used acupuncture as alter-
native ways of pain alleviation. It has further been shown
that the patients on combined therapy, including acu-
puncture, have on the average used smaller doses of
drugs in their treatment of herpes zoster pain (t=2.745;
p<0.05). The finding is in accordance with previous re-
ports according to which about 30% of individuals posi-
tively react to acupuncture and are prone to positive pla-
cebo effects17–20.
As shown in Table 2, self-assessment of satisfaction
with life quality in patients with herpes zoster is moder-
ate (M=3.08), while self-assessment of the need for medi-
cal therapy is high (M=3.15), and so is the assessment
concerning difficulties in performing the activities of
daily living resulting from pain (M=3.8). As regards the
essential psychological variables of satisfaction with one’s
own life and enjoyment in life, their average results
(M=2.46) show that the study subjects are not satisfied
with their health, but very much enjoy in their lives
(M=2.6).
Katz et al. (2004) have found that the HZ patients
more often exhibit the symptoms of depression and anxi-
ety than do non-HZ patients12. The authors also state
that 30% of their patients report that pain interferes
with their everyday physical and social functioning. The
correlation between sensory and affective types of pain
and life quality with regard to health, Katz has found out
that sensory pain contributes to diminished physical
functioning of the patients, whereas affective types of
pain interfere with their social functioning and aggra-
vates their mental states. In our study the most fre-
quently reported affective type of pain is that described
as exhausting pain (M=0.93). However, the overall aver-
age result in the scale of affective pain is not high
(M=2.66, SD= 3.24), while the results on sensory scale
are much higher (M=13.1, SD=5.23). This could lead to
a conclusion that the patients are more focused toward
sensory pain and physical limitations caused by it23.
The intensity of pain has also been found to signifi-
cantly affect the quality of life, especially so in patients
suffering from chronic and severe pain12,21. The quality
of life can be seriously deteriorated in patients with her-
pes zoster diagnosis since the symptoms of the disease af-
fect many aspects of daily living. Besides pain, the pa-
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TABLE 1
DECREASE OF PAIN INTENSITY IN VAS FOLLOWING
SIX-MONTH TREATMENT
PAIN VAS
Before therapy After therapy
N % N %
Weak 0–3 0 0 18 39.1
Moderate 4–6 10 21.7 28 60.9
Severe 7–10 36 78.2 0 0
TABLE 2
RESULTS OBTAINED FOR THE FOLLOWING SCALES: SATISFACTION WITH LIFE, ENJOYING LIFE, ASSESSMENT OF INABILITY
TO PERFORM THE ACTIVITIES OF DAILY LIVING BECAUSE OF PAIN; N=46.
M SD Min-Max
How would you assess the quality of your life? 3.08 0.76 1–5
How satisfied are you with your health? 2.46 1.12 1–5
How much does your pain prevent you from doing your daily activities? 3.8 0.8 1–5
How much medical treatment do you need in your life? 3.15 0.8v 1–5









tients can experience other physical problems interfering
with their everyday functioning, e.g. at work, leisure ac-
tivities, family life14,22,23.
Conclusion
Comprehensive assessments of pain are necessary for
clinical research on the epidemiology, natural history,
pathophysiological mechanisms, treatment and preven-
tion of pain in herpes zoster and PHN. Comprehensive
assessment emphasizes the importance of interdisciplin-
ary approach to the diagnosis and treatment of herpes
zoster pain, combining the pharmacological and psycho-
logical approaches in pain reduction. The future studies
should include investigation of psychological components
of pain and carry out evaluation of pain therapy taking
into consideration the quality, intensity, location and du-
ration of pain together with its influence on the patient’s
life quality.
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KVALITETA BOLI KOD PACIJENATA OBOLJELIH OD HERPES ZOSTERA
S A @ E T A K
Tipi~nom klini~kom slikom Hepres zostera dominiraju jaki bolovi koji uglavnom traju i nakon povla~enja osipa.
Istra`ivanja pokazuju da se se kod pacijenata sa ovom dijagnozommogu pojaviti razli~ite vrste boli koje variraju u svojoj
pojavnosti, intenzitetu, kvalitetu, lokaciji i trajanju, stoga je jako va`no analizirati sve pobrojane komponente. Cilj
istra`ivanja je bio procijeniti navedene komponente boli kod pacijenata oboljelih od herpes zostera. Sudionici su bili 46
pacijenata sa dijagnozom herpes zostera koji su lije~eni u Ambulanti za bol Klinike za traumatologiju, Zagreb u 2010.
godini. Kori{tene mjere za procjenu boli i njenog utjecaja na neke psihosocijalne aspekte `ivota su: SF McGill Pain
Questionnaire, VAS (vizualna analogna skala), Samoprocjena zadovoljstva `ivotom, zdravljem i u`ivanja u `ivotu. Ta-
ko|er su kontorlirane sociodemografske varijable, klini~ke karakteristike pacjenata te broj i vrsta analgetika kori{te-
nih u tretmanu. Rezultati pokazuju da pacijenti naj~e{}e opisuju bol kod herpes zostera po intenzitetu kao jaku i u
slijede}im kvalitetama: probadaju}u, bolnu, `are}u i o{tru. Rezultati tako|er ukazuju na velik utjecaj boli na dnevne
aktivnosti pacijenata, zadovoljstva `ivotom, zdravljem i u`ivanja u `ivotu. Dobiveni rezultati upu}uju na va`nost opse`-
ne evaluacije boli kod herpes zostera i njenom koristi kod budu}ih klini~kih istra`ivanja i prevencije ovog bolnog sin-
droma.
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